Cardioprotection by KATP channels in wild-type hearts and hearts overexpressing A1-adenosine receptors

被引:45
作者
Headrick, JP
Gauthier, NS
Morrison, R
Matherne, GP
机构
[1] Griffith Univ, Rotary Ctr Cardiovasc Res, Southport, Qld 4217, Australia
[2] Univ Virginia, Hlth Sci Ctr, Dept Pediat, Charlottesville, VA 22908 USA
[3] Univ Virginia, Hlth Sci Ctr, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2000年 / 279卷 / 04期
关键词
contracture; ischemia; mouse; reperfusion; transgenic;
D O I
10.1152/ajpheart.2000.279.4.H1690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the role of mitochondrial ATP-sensitive K+ (K-ATP) channels in modifying functional responses to 20 min global ischemia and 30 min reperfusion in wild-type mouse hearts and in hearts with similar to 250-fold overexpression of functionally coupled A(1)-adenosine receptors (A(1)ARs). In wild-type hearts, time to onset of contracture (TOC) was 303 +/- 24 s, with a peak contracture of 89 +/- 5 mmHg. Diastolic pressure remained elevated at 52 +/- 6 mmHg after reperfusion, and developed pressure recovered to 40 +/- 6% of preischemia. A(1)AR overexpression markedly prolonged TOC to 517 +/- 84 s, reduced contracture to 64 +/- 6 mmHg, and improved recovery of diastolic (to 9 +/- 4 mmHg) and developed pressure (to 82 +/- 8%). 5-Hydroxydecanoate (5-HD; 100 mu M), a mitochondrial K-ATP blocker, did not alter ischemic contracture in wild-type hearts, but increased diastolic pressure to 69 +/- 8 mmHg and reduced developed pressure to 10 +/- 5% during reperfusion. In transgenic hearts, 5-HD reduced TOC to 348 +/- 18 s, increased postischemic contracture to 53 +/- 4 mmHg, and reduced recovery of developed pressure to 22 +/- 4%. In summary, these data are the first to demonstrate that endogenous activation of K-ATP channels improves tolerance to ischemia-reperfusion in murine myocardium. This functional protection occurs without modification of ischemic contracture. The data also support a role for mitochondrial K-ATP channel activation in the pronounced cardioprotection afforded by overexpression of myocardial A(1)ARs.
引用
收藏
页码:H1690 / H1697
页数:8
相关论文
共 42 条
[1]   POTASSIUM CHANNELS AND PRECONDITIONING OF ISOLATED RABBIT CARDIOMYOCYTES - EFFECTS OF GLYBURIDE AND PINACIDIL [J].
ARMSTRONG, SC ;
LIU, GS ;
DOWNEY, JM ;
GANOTE, CE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (08) :1765-1774
[2]   Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: Effects of a protein phosphatase inhibitor, fostriecin [J].
Armstrong, SC ;
Kao, R ;
Gao, W ;
Shivell, LC ;
Downey, JM ;
Honkanen, RE ;
Ganote, CE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (11) :3009-3024
[3]   BLOCKADE OF ISCHEMIC PRECONDITIONING IN DOGS BY THE NOVEL ATP DEPENDENT POTASSIUM CHANNEL ANTAGONIST SODIUM 5-HYDROXYDECANOATE [J].
AUCHAMPACH, JA ;
GROVER, GJ ;
GROSS, GJ .
CARDIOVASCULAR RESEARCH, 1992, 26 (11) :1054-1062
[4]   Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton [J].
Baines, CP ;
Liu, GS ;
Birincioglu, M ;
Critz, SD ;
Cohen, MV ;
Downey, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (04) :H1361-H1368
[5]  
Chen EP, 1996, CIRCULATION, V94, P412
[6]   HYPOXIC DILATION OF CORONARY-ARTERIES IS MEDIATED BY ATP-SENSITIVE POTASSIUM CHANNELS [J].
DAUT, J ;
MAIERRUDOLPH, W ;
VONBECKERATH, N ;
MEHRKE, G ;
GUNTHER, K ;
GOEDELMEINEN, L .
SCIENCE, 1990, 247 (4948) :1341-1344
[7]   Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: P-31 NMR studies [J].
Docherty, JC ;
Gunter, HE ;
Kuzio, B ;
Shoemaker, L ;
Yang, LJ ;
Deslauriers, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (06) :1665-1673
[8]   KATP-channel activation:: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation [J].
Ford, WR ;
Lopaschuk, GD ;
Schulz, R ;
Clanachan, AS .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (04) :639-646
[9]  
GALINANES M, 1990, CARDIOSCIENCE, V1, P127
[10]  
GALINANES M, 1990, CAN J CARDIOL, V6, P83